A rare case of SRD5A3-CDG in a patient with ataxia and telangiectasia: A case report
- PMID: 36439385
- PMCID: PMC9684675
- DOI: 10.1002/ccr3.6564
A rare case of SRD5A3-CDG in a patient with ataxia and telangiectasia: A case report
Abstract
Steroid 5α-reductase type 3 congenital disorder of glycosylation (SRD5A3-CDG) is an extremely rare congenital disease. Common manifestations are developmental delay, intellectual disability, ophthalmological abnormalities, cerebellar abnormalities, ataxia, and hypotonia. Here, we discuss a seven-year-old boy with SRD5A3-CDG (homozygous variant c.57G>A [p.Trp19Ter]), featuring the unprecedented finding of telangiectasia.
Keywords: Allergy and immunology; Genetics; Pediatrics; SRD5A3‐CDG.
© 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
Conflict of interest statement
None.
Figures
References
-
- Kousal B, Honzik T, Hansikova H, et al. Review of SRD5A3 disease‐causing sequence variants and ocular findings in steroid 5α‐reductase type 3 congenital disorder of glycosylation, and a detailed new case. Folia Biol. 2019;65:134‐141. - PubMed
-
- Lipiński P, Cielecka‐Kuszyk J, Czarnowska E, Bogdańska A, Socha P, Tylki‐Szymańska A. Congenital disorders of glycosylation in children – Histopathological and ultrastructural changes in the liver. Pediatr Neonatol. 2021;62(3):278‐283. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Molecular Biology Databases